What SpaceX's IPO Means for Tech Stocks, and Coping With Panic Attacks

What It Covers

Scott Galloway analyzes SpaceX's post-IPO decline and its implications for Anthropic and OpenAI's upcoming listings, advises on portfolio diversification amid potential 40% market correction risk, and shares personal strategies for managing panic attacks through medication, practice, and behavioral exposure.

Key Questions Answered

• •SpaceX IPO mechanics: SpaceX opened at $150 against a $135 IPO price, peaked near $210-230 for a $2.8 trillion market cap, then shed $750 billion in under two weeks to close at $153. Despite the 30% drop from peak, the IPO still succeeded as a branding event engineered by banks to manufacture a predictable ~20% first-day pop.
• •OpenAI's IPO delay signal: Galloway argues OpenAI's stated delay until 2027 due to market volatility is misleading. The real driver is deteriorating financials — slowing growth that cannot justify massive CapEx commitments. Expect OpenAI to pursue aggressive cost-cutting over the next six months to clean up its balance sheet before attempting a public listing.
• •Portfolio diversification strategy: The S&P 500 no longer provides true diversification since 40% of it is concentrated in just 10 companies. Galloway recommends spreading across asset classes including fixed income, which now offers meaningful yield, and international geographies — particularly European equities, which are currently undervalued and historically represent a buying opportunity.
• •Market timing risk and tax drag: Attempting to exit overvalued tech positions triggers capital gains taxes, requiring approximately 23% market outperformance just to break even after re-entry. GMO research shows every 1% monthly market cap increase historically correlates with a 7.5% decline in subsequent 12-month returns, suggesting a potential 40% broader market correction tied to upcoming mega-IPOs.
• •Panic attack management framework: The 333 technique — identifying three visible objects, three audible sounds, and moving three body parts — combined with Huberman's double-inhale breath hold provides immediate nervous system regulation. Beta blockers like propranolol reduce fight-or-flight response for high-stakes situations. Long-term resolution comes from repeated exposure rather than avoidance, with frequency reducing episode occurrence significantly.